Specifies the number of studies evaluated orselected
Steps, and targets of constructing a good review article are listed in Table 3 . To write a good review article the items in Table 3 should be implemented step by step. [ 11 – 13 ]
Steps of a systematic review
Formulation of researchable questions | Select answerable questions |
Disclosure of studies | Databases, and key words |
Evaluation of its quality | Quality criteria during selection of studies |
Synthesis | Methods interpretation, and synthesis of outcomes |
It might be helpful to divide the research question into components. The most prevalently used format for questions related to the treatment is PICO (P - Patient, Problem or Population; I-Intervention; C-appropriate Comparisons, and O-Outcome measures) procedure. For example In female patients (P) with stress urinary incontinence, comparisons (C) between transobturator, and retropubic midurethral tension-free band surgery (I) as for patients’ satisfaction (O).
In a systematic review on a focused question, methods of investigation used should be clearly specified.
Ideally, research methods, investigated databases, and key words should be described in the final report. Different databases are used dependent on the topic analyzed. In most of the clinical topics, Medline should be surveyed. However searching through Embase and CINAHL can be also appropriate.
While determining appropriate terms for surveying, PICO elements of the issue to be sought may guide the process. Since in general we are interested in more than one outcome, P, and I can be key elements. In this case we should think about synonyms of P, and I elements, and combine them with a conjunction AND.
One method which might alleviate the workload of surveying process is “methodological filter” which aims to find the best investigation method for each research question. A good example of this method can be found in PubMed interface of Medline. The Clinical Queries tool offers empirically developed filters for five different inquiries as guidelines for etiology, diagnosis, treatment, prognosis or clinical prediction.
As an indispensable component of the review process is to discriminate good, and bad quality researches from each other, and the outcomes should be based on better qualified researches, as far as possible. To achieve this goal you should know the best possible evidence for each type of question The first component of the quality is its general planning/design of the study. General planning/design of a cohort study, a case series or normal study demonstrates variations.
A hierarchy of evidence for different research questions is presented in Table 4 . However this hierarchy is only a first step. After you find good quality research articles, you won’t need to read all the rest of other articles which saves you tons of time. [ 14 ]
Determination of levels of evidence based on the type of the research question
I | Systematic review of Level II studies | Systematic review of Level II studies | Systematic review of Level II studies | Systematic review of Level II studies |
II | Randomized controlled study | Crross-sectional study in consecutive patients | Initial cohort study | Prospective cohort study |
III | One of the following: Non-randomized experimental study (ie. controlled pre-, and post-test intervention study) Comparative studies with concurrent control groups (observational study) (ie. cohort study, case-control study) | One of the following: Cross-sectional study in non-consecutive case series; diagnostic case-control study | One of the following: Untreated control group patients in a randomized controlled study, integrated cohort study | One of the following: Retrospective cohort study, case-control study (Note: these are most prevalently used types of etiological studies; for other alternatives, and interventional studies see Level III |
IV | Case series | Case series | Case series or cohort studies with patients at different stages of their disease states |
Rarely all researches arrive at the same conclusion. In this case a solution should be found. However it is risky to make a decision based on the votes of absolute majority. Indeed, a well-performed large scale study, and a weakly designed one are weighed on the same scale. Therefore, ideally a meta-analysis should be performed to solve apparent differences. Ideally, first of all, one should be focused on the largest, and higher quality study, then other studies should be compared with this basic study.
In conclusion, during writing process of a review article, the procedures to be achieved can be indicated as follows: 1) Get rid of fixed ideas, and obsessions from your head, and view the subject from a large perspective. 2) Research articles in the literature should be approached with a methodological, and critical attitude and 3) finally data should be explained in an attractive way.
Intended for healthcare professionals
Three research papers on MDMA assisted psychotherapy have been retracted by the journal Psychopharmacology because of “protocol violations amounting to unethical conduct” by researchers at a study site.
In the retraction notices the journal said that the authors were aware of the violations when they submitted the articles but failed to disclose them or remove the affected data from their analysis. 1 2 3 All three papers related to phase 2 randomised controlled trials for MDMA assisted therapy, with similar authors listed for all three papers.
Although the notices did not detail what the …
BMA Member Log In
If you have a subscription to The BMJ, log in:
Subscribe from £184 *.
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for: £50 / $60/ €56 ( excludes VAT )
You can download a PDF version for your personal record.
Buy this article
BMC Health Services Research volume 24 , Article number: 932 ( 2024 ) Cite this article
Metrics details
Upper gastrointestinal cancers (UGICs) are increasingly prevalent. With a poor prognosis and significant longer-term effects, UGICs present significant adjustment challenges for individuals with cancer and their informal caregivers. However, the supportive care needs of these informal caregivers are largely unknown. This systematic review of qualitative studies synthesises and critically evaluates the current evidence base on the experience of informal caregivers of individuals with UGIC.
A Joanna Briggs Institute systematic review was conducted. Searches were performed in four databases (MEDLINE, PsycINFO, Embase, CINAHL) from database inception to February 2021. Included studies explored experiences of informal caregivers of individuals diagnosed with primary cancer of the oesophagus, stomach, pancreas, bile duct, gallbladder, or liver. Studies were independently screened for eligibility and included studies were appraised for quality by two reviewers. Data were extracted and synthesised using meta-aggregation.
19 papers were included in this review, and 328 findings were extracted. These were aggregated into 16 categories across three findings: (1) UGIC caregiver burden; UGIC caregivers undertake extensive responsibilities, especially around patient diet as digestion is severely impacted by UGICs. (2) Mediators of caregiver burden; The nature of UGICs, characterised by disruptive life changes for caregivers, was identified as a mediator for caregiver burden. (3) Consequences of caregiver burden: UGIC caregivers’ experiences were shaped by unmet needs, a lack of information and a general decline in social interaction.
The findings of this review suggest the need for a cultural shift within health services. Caregiving for UGIC patients is suggested to adversely affect caregivers’ quality of life, similarly to other cancer caregiving populations and therefore they should be better incorporated as co-clients in care-planning and execution by including them in discussions about the patient’s diagnosis, treatment options, and potential side effects.
Peer Review reports
The National Institute for Clinical Excellence (NICE) [ 1 ] define upper gastrointestinal cancers (UGICs) as cancers of the oesophagus, stomach, pancreas, bile duct/gallbladder, or liver. Of all new cancer diagnoses in 2020 globally, 16.6% were UGICs [ 2 ]. Incidence of UGICs is increasing in countries under economic transition, and in Western countries due to heightened exposure to certain risk factors [ 3 ]. Overall prevalence of UGICs is also expected to rise annually with growing life expectancy and improved diagnostics [ 4 ]. Despite this, UGICs still have a uniquely poor prognosis in comparison to other cancer populations [ 5 ]. UGICs do not typically benefit from screening programmes and individuals are more likely to present at diagnosis with advanced disease [ 6 ]. This is compounded by a high rate of recurrence for individuals able to receive curative treatment [ 7 , 8 , 9 ]. As a result, UGICs persistently account for a significant proportion of global cancer deaths; 27.1% in 2020 [ 2 ]. Poor prognosis contributes significantly to the heightened disease burden of UGIC, alongside increased utilisation of health services due to the complexity of the treatment trajectory and symptom management [ 10 , 11 ]. In comparison to other cancer populations, having UGIC is associated with late consultation with palliative care services [ 12 ] meaning patients and their families have delayed access, if any, to supportive interventions such as counselling, psycho-education, financial advice and structured family meetings [ 13 ].
The supportive care needs of the sizeable population of individuals with UGIC are considerable, with sustained late and longer-term effects. In addition to the common sequalae from cancer diagnosis and treatment, disruption to the digestive system presents problems with swallowing, nausea and keeping food down, a modified diet, extreme changes in weight, chronic pain and living with a stoma [ 14 , 15 ]. The poor prognosis and longer-term effects present a challenge in adjustment both for the individual with UGIC and their informal caregiver, defined as “close persons” who may be related to the diagnosed individual (siblings, relatives, or spouses) or not (friends, neighbours). A caregiver is anyone identified as such by the patient to provide unpaid ongoing care and support [ 16 ]. Examples of challenges for caregivers include learning new practical skills such as managing negative responses to foods, providing a new diet, monitoring weight changes, chronic pain management and stoma management [ 17 , 18 ]. With biomedical advances leading to a reduction in hospital stay length [ 19 ], there is increasing emphasis placed on the role of the UGIC caregiver to provide support to the individual with cancer in the community.
This unique caregiver population face distinct challenges which contribute to caregiver burden which reflects the need for further research into their experiences. For example, due to changes in the diet of the individual with UGIC, the social aspect of dining for both is compromised and can lead to feelings of loneliness, anxiety, and shame [ 20 , 21 ]. Evidence of caregiver burden is suggested by high levels of anxiety and depression. In caregivers of post-treatment oesophageal cancer patients, 30% of caregivers reported moderate-high levels of anxiety and 10% reported moderate-high levels of depression, alongside a significant fear of recurrence [ 22 ]. Research suggests that UGIC caregivers may experience higher levels of psychological distress than the individual with UGIC, and that clinical levels of anxiety and depression may be sustained in the longer-term [ 22 , 23 ]. However it is worth noting that a lot of the effects of UGIC caregiving acknowledged in the literature are consistent with the general experience of informally providing care and as such there is scope to apply the beneficial practices from other settings (both extra-GI cancer and non-cancer).
It is crucial that we recognise the role of caregivers as co-clients and understand the experiences of this significant caregiver population. Caregivers’ personal experiences are inherently subjective, and due to this subjective nature, a qualitative research approach is optimal [ 24 ]. A synthesis of existing qualitative studies will help to establish a knowledge base on the experience of informal caregivers of individuals with UGIC and will help to inform the provision for supportive care. An initial search of PROSPERO, MEDLINE, the Cochrane Database of Systematic Reviews and the Joanna Briggs Institute (JBI) Database of Systematic Reviews and Implementation Reports was conducted and no current or underway systematic reviews on the topic were identified.
This qualitative systematic review aims to synthesise the best available evidence on the experiences of informal caregivers supporting individuals diagnosed with UGIC.
This systematic review was conducted following the JBI approach to qualitative systematic reviews [ 25 ]. A protocol was pre-registered in PROSPERO (registration number CRD42021235354). The systematic review is reported according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Protocols (PRISMA-P) statement [ 26 ].
An initial limited search of MEDLINE (Ovid) and PsycINFO (Ovid) was undertaken using the following keywords: Oesophageal cancer OR Stomach cancer OR Gastrointestinal cancer OR pancreas cancer OR gallbladder cancer OR liver cancer AND caregiver AND Qualitative. The text words contained in the titles and abstracts of relevant articles, and the index terms used to describe the articles were used to develop a full search strategy for MEDLINE and adapted for the other databases.
The final search strategy (Additional information 1 ) was then employed against four databases: MEDLINE (Ovid), PsycINFO (Ovid), Embase (Elsevier) and CINAHL (EBSCOhost). Each database was searched on 12th February 2021.
Following the formal searches, all identified citations were collated and uploaded into Endnote [ 27 ] to identify and remove duplicates. Rayyan reference management software [ 28 ] was then used by independent two reviewers (DD, MF) to screen titles and abstracts against the eligibility criteria. Potentially relevant articles were retrieved in full and screened against the eligibility criteria by two independent reviewers (DD, MF). Reasons for exclusion of papers at full text review were recorded. Any disagreements that arose between the reviewers at each stage of the selection process was resolved through discussion (DD, MF), or with an additional reviewer (LGW). The reference list and citation list of all eligible articles was searched for additional studies.
This review included studies exploring experiences of adults (≥ 18 years of age) who are informal caregivers of individuals diagnosed with UGIC at any stage within the disease process. This included those diagnosed with cancer of the oesophagus, stomach, pancreas, bile duct, gallbladder, or liver [ 1 ]. This diagnosis must be the primary cancer site. Studies involving informal caregivers of individuals who had secondary gastrointestinal system metastases were not included.
A caregiver is anyone identified as such by the patient to provide unpaid ongoing care and support [ 16 ]. Paid professional caregivers were not included. The caregivers included provided various services, such as practical (providing transport, overseeing meals) or emotional support roles in caring for the patient. Caregivers with any gender or ethnicity were considered for inclusion. Both active and bereaved caregivers were eligible, if discussing their pre-bereavement experience.
Studies which reviewed experiences of multiple groups (e.g., patients, caregivers, healthcare professionals) or multiple cancers beyond the remit of UGIC were included, provided the data pertaining to informal caregivers and UGICs was clearly delineated and could be extracted separately. Where data was hard to distinguish regarding participant-type or cancer-type, the study was only included if at least 50% of the sample size was drawn from the target population.
The review included qualitative studies that looked at caregivers’ experiences of caring for an individual with UGIC.
Studies for inclusion were based in any geographic location or setting. All care contexts were considered relevant (e.g., primary care, secondary, tertiary, community, or home settings).
Research studies considered for inclusion were focused on qualitative data including, but not limited to; designs such as phenomenology, grounded theory, ethnography, action research and feminist research. Mixed method studies were considered relevant if data from the qualitative component could be clearly extracted. Only English language studies were included.
Only empirical studies published in peer-reviewed journals were included. There was no restriction on publication year. Systematic reviews were not included, however relevant studies were harvested from them, when relevant. Editorials, opinion papers, case studies and any articles without relevant, original data were excluded, alongside grey literature.
Subsequently, two independent reviewers (DD, MF) critically appraised the included studies to evaluate the strength of the evidence for methodological quality using the JBI Critical Appraisal Checklist for Qualitative Research [ 29 ]. All studies, regardless of the results of their methodological quality, underwent data extraction and synthesis. One of the included studies employed use of free-test questionnaires [ 30 ], the robustness of which has been called into question by qualitative researchers as the data generated from these responses is rarely rich enough to provide the necessary strong insights [ 31 ]. However, the reviewers felt the robustness of this study was upheld by the fact that the researchers conducted a comprehensive search on existing literature prior to data collection, thus allowing questionnaire findings to be scaffolded onto existing conceptual frameworks.
Data were extracted using standardized JBI data extraction tool [ 32 ] by two independent reviewers (DD, MF). Each undertook data extraction for half of the articles and then checked the other reviewer’s data extraction. The extracted data included specific details about the population, context, study methods and the phenomena of interest relevant to the review objective. Disagreements between the reviewers were resolved through discussion. Four authors of papers were contacted to request missing or additional data for clarification mainly regarding breakdown of participant populations by cancer type of which no new information arose.
A finding is defined by the JBI as “a verbatim extract of the author’s analytic interpretation accompanied by either a participant voice, or fieldwork observations or other data.” [ 33 , p40]. Findings were identified through repeated reading of the text, and extraction of findings included any distinct analytic observation reported by authors with an accompanying illustration (Additional information 2 ).
Each finding was identified by an alphanumeric code (e.g., A1, A2, B1, etc.). Each letter corresponded to a study and each number to a unique finding. The progressive numbers indicate the order of the findings within the original article. Each finding was rated with one of three levels of credibility as per the ConQual system [ 34 ]:
Unequivocal - findings accompanied by an illustration that is beyond reasonable doubt and therefore not open to challenge.
Credible - findings accompanied by an illustration lacking clear association with it and therefore open to challenge.
Not Supported - findings are not supported by the data.
Qualitative research findings were pooled with the meta-aggregation approach and captured in a Microsoft Excel spreadsheet [ 33 ]. Findings were aggregated by assembling the findings and categorizing these findings based on similarity in meaning, then labelling the categories accordingly. Categories were then synthesised to produce a comprehensive set of synthesized findings. Two reviewers (DD, MF) repeatedly read the findings and developed a set of categories. To assess the quality and confidence of each qualitative finding synthesised within this review, authors utilised the ConQual system (Additional information 3 ), a tool used to assign ratings of confidence in synthesised qualitative research findings [ 34 ]. Only unequivocal and credible findings were included in the synthesis.
The combined database searches yielded 5465 records. After removing duplicates and screening studies against eligibility criteria (Fig. 1 ), the review included 19 studies [ 18 , 30 , 34 , 35 , 36 , 37 , 38 , 39 , 40 , 41 , 42 , 43 , 44 , 45 , 46 , 47 , 48 , 49 , 50 , 51 ]. Additional information 4 displays the characteristics of the 19 included studies.
PRISMA flowchart of study selection process
All included studies were published between 2004 and 2021. Most commonly, studies focused on caregivers of individuals with oesophageal cancer ( N = 7), or pancreatic ( N = 7), including one study of pancreatic and bile duct cancer. Other studies included caregivers of individuals with liver cancer ( N = 2), gastric cancer ( N = 1) and the gastrointestinal tract generally ( N = 2). Geographically, studies were conducted in eight regions. The largest group ( N = 6) were conducted in the US [ 35 , 37 , 38 , 39 , 40 , 41 ], followed by Denmark ( N = 3) [ 42 , 43 , 44 ]. Most samples included a variety of within-family caregivers ( N = 13), generally spouses/partners, children, and siblings. Others ( N = 3) looked specifically at spouses and three did not specify the caregiver-patient relationship. Most studies included a semi-structured interview format ( N = 12), others used focus groups ( N = 4), secondary analysis of existing data ( N = 2) or questionnaires ( N = 1).
The JBI Critical Appraisal Checklist [ 25 ] was used to establish the quality of the research. The included studies were generally of good quality, with all 19 papers achieving at least 60% across the ten JBI quality assessment criteria (Additional information 5 ). Within the JBI checklist there are five questions assessing study dependability, where the studies performed at a lower satisfactory level. Of the included papers, two achieved a 5/5 score on dependability questions, seven achieved 4/5, nine scored 3/5 and one scored 2/5. Only 26% of studies could adequately locate the researcher(s) culturally or theoretically and only 37% of papers addressed the influence of the researcher on the research and vice-versa. Conversely, nearly all papers adequately addressed the research methodology’s congruity on objectives, data collection, data representation and analysis.
Across the 19 studies, 328 supported findings were extracted, of which 239 were unequivocal and 89 were credible. Findings could be aligned into 23 categories with unique core meanings, which were then synthesised into three findings: (1) UGIC caregiver burden; (2) Mediators of caregiver burden; (3) Consequences of caregiver burden (Additional information 6 ). Figure 2 outlines how the categories relate to the overarching synthesised findings. To remain grounded in the data, the actual participants’ words are used throughout the narrative and double quotation marks illustrate a direct caregiver quote. References given after a quotation links the quote to the study as outlined in Additional information 2 .
Structural arrangement of categories and synthesised findings
As caregivers began supporting those with UGIC, they faced numerous challenges to adjustment. This largely stemmed from efforts to integrate a broad and complex caregiving role within their existing routine. Difficulties such as disruption to daily routines and meals impacted caregivers’ psychological wellbeing. Caregivers were often unprepared for this life disruption, leading them to seek out information from which to learn and distribute to others.
The extent of responsibilities on UGIC caregivers was perceived as broad and complex, with an ‘all encompassing’ focus on patient outcomes. UGIC caregivers ‘assume different roles’ [ 42 ].
“The food thing is omnipresent. We have been told that he is not allowed to have further weight loss (K23).
Specific responsibilities included working around reduced appetite and oral intake; monitoring physical signs e.g., patient weight; perioperative management such as care of surgical wounds and organising medical appointments and treatments.
“We’d have to keep. . .going with all the medical appointments and surgery and treatment” (B11).
Treatment for and progression of UGIC severely impacts the patient’s relationship with food; with diet quantity and content at times significantly altered. Adaption for the caregiver involved learning about dietary modifications and management of digestive symptoms such as dysphagia. Several studies found that the new dietary restrictions were a source of worry for caregivers regarding the patients’ weight [ 44 , 45 , 46 , 47 ]. The social importance of food was a common theme throughout the included studies, with interruption to established social norms perceived as distressing. Mealtimes are considered a ‘unifying family ritual’ [ 49 ], but when mealtimes constantly serve to remind caregivers of their responsibility of monitoring, they became a potential source of distress.
“I can’t get Bernard out of the small meals. . I have to ring him every day from work to tell him to eat” (A7).
UGIC was experienced as coming unexpectedly into caregivers’ lives, intruding on their existing routines, for instance, as working professionals or parents. Caregivers described their responsibilities as time and energy-consuming. This conflict caused caregivers to feel a loss of control [ 44 ]. Caregiving responsibilities for UGICs demanded commitment over a long-time frame, impacting caregivers’ employability and their ‘own social life’ [ 35 ]:
“It’s changed my daily routine. It totally disrupted my life. I have to rearrange a lot of things such as my kids , my work , and getting help for my house cleaning” (J4).
Caregivers expressed being ill-equipped and unqualified to manage the needs of the UGIC patient. Caregivers reported feeling out of their depth, partially attributed to the lack of available support, relating to patients’ medical requirements:
“I went , ‘You’re not supposed to call 911? What am I supposed to do? What if he just dies right here?’ I mean , it seems they should have somebody say , ’OK , if he’s with you , then here’s the procedure…[The nurse] gave me really no support about what to do” (R21).
Caregivers sometimes felt misled about the extent of their new responsibilities, as while the patient was cared for in hospital by medical staff, they could not gauge what caregiving at home would involve.
“I wish they would have talked to me about it as well… it was a bit of a shock. …but the next morning it all dawned on me that I had just replaced a whole team” (E10).
Caregivers perceived a key responsibility was to make executive decisions in the dissemination of information, for instance symptomatology, treatment plans and prognosis. Caregivers felt they were the ‘conduit’ [ 18 ] through which medical details were communicated to members of the extended social circle, a time-consuming role where they spent “hours on the phone telling everyone what is happening” (I32).
The caregivers also viewed their role as giving healthcare providers (HCPs) valuable insight into how the patient was coping outside of the medical setting:
“[describing a discussion during a clinical consultation , contradicting the patient] It is not correct that you almost eat as usual. You are eating food of more liquid substance than you usually do and your drinks are high-protein” (C1).
While supporting patients with UGIC, caregivers are exposed to mediators which could increase or reduce caregiver burden, including their use of coping strategies, financial and social resources, and their caregiving context. For instance, higher levels of social support helped alleviate some caregiver burden. Similarly, how excluded a caregiver felt in the medical setting influenced the burden experienced.
Many studies reported that caregivers perceived they are often kept at a distance in medical settings, increasing caregiver burden. Although some caregivers felt this was fitting and chose to take a ‘subordinate position’ [ 44 ], others struggled with a sense of exclusion, which commonly left unresolved questions:
“…my husband could ask questions , but I didn’t have the space to ask questions , not unless my husband allowed it” (K39).
In such cases, caregivers relied on HCPs’ judgement. Caregivers described only being ‘seen’ if they actively called attention to themselves [ 41 ]. Caregivers experienced being left out of important decisions.
Caregivers expressed wanting to ask questions without the patient present but felt they had no opportunity to directly communicate with HCPs. This pervasive, default invisibility was perceived as disempowering:
“No health professionals involved me in this decision” (K38).
The degree and quality of support received by caregivers varied and shaped their overall caring experience. The support network is especially beneficial for normalisation of caregivers’ experiences, providing hope and reducing feelings of isolation.
“it was only when I came here that I started talking to people … it was just like a breath of fresh air. . this dumping syndrome , he [the patient] wasn’t the only one” (A10).
Support could be from spiritual groups ( “I have a lot of people that stand behind me…” (B19), empathetic HCPs ( “It’s easier to talk with a nurse when it concerns important questions. You may receive quite good and reassuring answers” (H22) or peers who have undergone a similar caregiving experience, and therefore could reliably address and empathise with caregivers’ challenges.
Caregivers reported financial pressure as they had to consider the dyad’s financial situation while one or both members may not be able to work. Providing full-time care was a drain on caregivers’ resources, time, and money. Caregivers struggled with financial planning for the future in the face of prognostic ambiguity.
“We talked about if we should stay on at the house or sell it” (K6).
There were additional pressures on dyads living in countries where utilisation of private health services is the norm.
“Now my grandmother is sick and I can understand how high is the cost of the disease” (D5).
The caregiving experience was shaped by the inter-dyad relationship. Some caregivers reported having an emotionally distant relationship with the patient before the diagnosis which led to poor attachment during the cancer trajectory. Others reported a decline in the relationship quality due to cancer-related pressures.
“When I got upset , I would say to my husband , ‘You got cancer because you didn’t listen to me! You deserve it!” (F35).
Others noted a shift within the relationship, transitioning from ‘caregiver’ to ‘curer’ or from a spousal role to a parental one [ 45 ] especially where the caregiver was actively involved in delivering treatment:
“Sometimes I felt like a mother talking to a child: ‘Remember to do this and that’ ” (K29).
Caregivers experienced reciprocal suffering when seeing the patient suffer, especially if an established close relationship existed:
“up when the patient is up and down when the patient is down” (I21).
The cancer experience was perceived to result in significant distress for caregivers. To address this challenge, caregivers engaged in positive emotion-focused coping strategies to directly regulate distress. Many caregivers reported trying to maintain positive thinking. One participant recalled using humour:
“Sometimes you can’t believe what happens and the only thing you can do is laugh” (I41).
Maintaining a positive outlook was perceived to involve “looking for the good in every situation” and by being selective about what news caregivers received through ‘denial’ and “choosing what to hear” (I44). Conversely, another study described positivity as an open-minded reflection on the conflict between current suffering and spiritual beliefs [ 38 ]. Caregivers described how formally addressing their feelings through therapy was also helpful.
Individuals were limited in their opportunity for emotional expression. Caregivers described hiding their own negative thoughts from the patient and took practical measures to divert the patient’s attention by doing “normal things like [going] for a drive and [having] visits from our children and grandchildren” (C15).
Caregivers perceived challenges around a lack of information from HCPs regarding UGIC’s pathology and related management options. The experiences of caregivers included difficulties in accessing information.
“We have little information in these areas. When we go to the physician’s office for treatment , the doctor is too busy to give us information in this regard and he merely visits the patients. When we see that nobody could survive from such diseases , we get worried more” (D9).
Caregivers addressed the information challenge by persistently seeking information relating to the disease itself, namely cancer-related symptomatology, prognosis, and treatment options (including alternative therapies). Caregivers referred to sources like medically knowledgeable peers, the internet and print (e.g., encyclopaedias). HCPs were trusted for honest information, with their word choices and body language carefully analysed:
“When my husband and I visit the doctor together , you see when he opens the door that there is no good news today” (H6).
Caregivers were especially empowered when they could differentiate between symptoms due to disease progression and treatment-related adverse effects.
There were consequences of caregiver burden such as feelings of helplessness, distress, anger, guilt and a strong fear of losing the patient. Conversely, there was potential for positive outcomes as caregivers experienced growth and feelings of hope.
When recounting the most involved phase of providing care, active treatment, many caregivers reported experiencing heightened distress. One caregiver perceived gastric cancer a ‘death sentence’ [ 49 ], and seeing the patient struggle with the effects of disease and treatments an unbearably ‘ challenging experience’ [ 40 ]. This distress also affected children with one spouse noting their child’s “grades dropped disastrously during his first term” (H14).
Helplessness originates from a lack of control over the disease progression. A particular source of distress were the delays along the cancer trajectory, especially at diagnosis due to the ambiguous presentation of UGICs and lack of control over symptom management.
“It is distressing seeing him in pain all the time” (E6).
Caregivers experienced a sense of guilt and anger because they perceived stigma from society towards certain cancers. Others may assume that the diagnosis was caused by the patient’s behaviours and therefore indirectly the caregiver may also have been involved. A few studies described this judgement from society towards the patient, with caregivers fearing that others would see the diagnosis as a justified fate:
“You know , when you say cirrhosis of the liver , they think , ‘Oh , you drank yourself’” (R7).
Caregivers also harboured anger at being forced to take on caregiving responsibilities, describing they had “been dealt a bad hand” (I39); however, they felt guilty for feeling this way.
Due to the unpredictability of UGICs, caregivers described living in constant dread of the patient’s health declining, and the potential for disease progression or recurrence:
“I am not sure I am going to like the answers I get. Maybe it is better not to know so very much but to do like the ostrich , to bury your head in the sand and hope for the best and keep your fingers crossed” (H41).
Caregivers were fearful of any new physical or psychological symptoms in patients, especially weight-loss, as caregivers saw this as a marker of recurrence. Further, caregivers feared the cancer would progress to a terminal stage which meant they were afraid of the means through which the bereavement would occur and their own subsequent reaction.
“the fear of not being sure of how it’s going to happen and how I’m going to react…I’m afraid of losing him” (L1).
The high mortality associated with most UGICs caused several caregivers to experience acceptance, with the realisation of the long-term impact of their loved one’s cancer and possibility of bereavement.
“The possibility is there for one of us dying quickly” (K5).
Caregivers commonly reported experiencing isolation within their unique role, feeling unable to share their anxieties. As patients were burdened already, caregivers did not want to unload their own worries on to the patient.
“And I had nobody to talk to…There was just nobody. I couldn’t let myself down , my guard down and I found the isolation terrible” (A3).
Loneliness was not only an ongoing concern, but a future threat as spousal caregivers relayed their fear of life post-bereavement.
Caregivers reflected that they saw the experience of caregiving as a catalyst for personal change, resulting in positive outcomes such as personal growth and appreciation for life, individually and within the relationship. Caregivers recounted that this unexpected, immense challenge had given them ‘ new perspectives about life’ [ 35 ]. Couples got to spend time together that they would not have had otherwise which led to an improved quality of relationship.
“We’ll talk three or four times a month. Where 10 years ago it might be 6 months or 10 months you know between phone calls” (B14).
The current study presents the first comprehensive synthesis of qualitative research on the experiences of caregivers of individuals with UGICs. This review is the first to systematically identify and synthesise the current evidence base on the experiences of informal caregivers of individuals with UGIC. Given the emergence of this prominent caregiver population, this review contributes to advancing cancer caregiver literature as a whole, an important area of study recognised by individuals with cancer, their family and healthcare professionals [ 52 ]. The review included 19 studies, presented synthesised findings, and identified aspects of caregiving experiences that UGIC caregivers have in common with other cancer caregivers, and aspects more distinct to UGICs. UGIC caregivers experience significant challenges contributing to high levels of burden which are mediated by social, psychological, and practical resources, as well as aspects of health service delivery. The consequences of caregiver burden are primarily negative, including distress, anger, fear, and loneliness.
Caregivers of UGIC patients experienced burden due to the breath and complexity of their role for which they felt unprepared. Caring involved incorporating novel skills into existing responsibilities, causing significant life disruption. Caregivers perceive burden in providing multifaceted care with demands that shift along the illness trajectory. For example, in the beginning caregivers felt it necessary to partake in provision of care, and due to UGIC treatment and disease progression, many responsibilities evolved to monitor and maximise physical health, such as diligent weight monitoring and meal preparation [ 45 , 46 , 47 ]. These findings align to the general cancer caregiver literature [ 53 ], with caregivers recognised in having steep initial learning curves to rapidly acquire skills to provide care. Only one of the 19 studies evaluated data over an extended period [ 45 ]. An extended review is needed to map supportive care resources available across the disease path and longitudinal studies tracking UGIC caregiver support needs across the illness trajectory is warranted.
One of the most reported findings in this review was informal caregivers’ continuous search for information related to their role. Many struggle to satisfy their informational needs at different stages of the disease trajectory contributing to caregiver burden. This corresponds with systematic review findings of Wang et al. [ 54 ] that informational needs were the most common unmet need of informal caregivers. To begin addressing this need, caregivers could be signposted to existing sources of general caregiver support information and interventions, such as Cancer Caring Coping [ 55 , 56 ]. These supports could be used to develop informational resources tailored for UGIC caregivers. A core information set has been developed to aid HCPs at consultation with UGIC patients, to ensure key information is being delivered [ 57 , 58 ] and now the focus of improving patient-carer education should be raising awareness of this key information toolkit to HCPs who commonly interact with this population. A similar approach could be utilised by identifying informational needs of UGIC caregivers at consultations and developing standardised information points delivered by HCPs to caregivers within those consultations. There is also potential to expand the pool of reliable sources of information to individuals outside of the HCP cohort, such as peer networks or psychologists in providing longitudinal support without necessarily adding to the cost burden required for the development of additional personnel and resources.
This review found caregivers experienced exclusion in the medical setting, suggesting enhanced communication between HCPs and caregivers could improve caregivers’ experience. Indeed, a qualitative study by Reblin et al. [ 59 ] identified communication within health services as a key driver for improving cancer caregiver support. One potential avenue to bridge the gap between HCPs and patient-caregiver dyad is incorporating better the clinical nurse specialist (CNS) [ 60 ] as these professionals can be a key contact for bi-directional communication between HCPs and caregivers. That is, caregivers support and help the clinical team to understand the patient’s progress and through this process HCPs acknowledge and include caregivers in the patient’s care. However, the current issue of under resourcing in cancer nursing would need to be addressed as it presently limits the amount of CNS time available to support caregivers [ 61 ].
One review finding specific to UGIC caregiver burden was the challenge around preparing meals. Taleghani and colleagues [ 62 ] mirror this, highlighting gastric caregivers experienced inadequate education in managing patient’s dietary requirements appropriately, resulting in feeling inefficient, uncomfortable, and fearful. Dietician-led interventions are typically patient focused [ 63 , 64 , 65 ]. However, this review highlights an opportunity for HCPs to include caregivers in dietician-led interventions as many caregivers assume responsibility over meal preparation and grocery shopping. The challenge around meals also has social consequences as meals are important social settings. Changes in eating behaviours can lead to both dyad members feeling isolated and lonely [ 18 , 66 ]. Loneliness is prevalent among people living with cancer and is influenced by cancer-specific and non-cancer specific risk factors, such as lack of social support [ 67 ]. There is less of an understanding of loneliness among UGIC caregivers compared to general cancer caregivers [ 68 ]. This is of concern as negative physical and mental health impacts of loneliness are well-established [ 69 , 70 ]. Peer support is the most used intervention to reduce caregivers’ loneliness, with strategies of psychoeducation and emotional support featuring prominently [ 71 ]. Research is needed to identify risk and protective factors for loneliness among UGIC caregivers.
In addition to loneliness, distress and negative affect were identified as consequences of UGIC caregiver burden. There is evidence of heightened distress and reduced physical and mental health among UGIC caregivers relative to UGIC patients [ 72 , 73 ]. This review also found that caregivers engage in emotion-focused strategies to cope with their caregiving role. A review by Teixeira et al. [ 74 ] found that among cancer caregivers, emotion-focused coping was related to higher distress, whereas problem-focused coping was related to better adjustment and reduced burden. There is a need to develop targeted theory-based psychosocial interventions for this caregiver group. The Transactional Theory of Stress and Coping (TTSC) framework could be utilised to understand how mediating processes specific to coping strategies influence distress and negative affect among UGIC caregivers [ 75 , 76 , 77 ], similar to how Bowan et al. [ 78 ] used a Baltes and Baltes [ 79 ] coping framework to develop interventions for cancer patients’ families. Candidate interventions could involve problem-solving and coping skills training [ 80 , 81 ], which could in turn ameliorate the negative consequences of caregiver burden. If effective with UGIC caregivers, such interventions could be extended to all caregivers as part of a standard care pathway. This review recommends further research to develop an understanding of adjustment in UGIC caregivers.
In contrast to the many negative consequences described by informal caregivers, there were a small group of findings which indicated some positive outcomes. These findings align with a review of the positive aspects of caregiving, which reported improved relationship quality, reward, fulfilment, and personal growth [ 82 ]. The review concluded that positive aspects of caregiving are interconnected and suggested, in addition to interventions reducing negative burden, that interventions could be developed to enhance positive outcomes, such as personal growth. Tedeschi and Calhoun’s Transformational Model (TM) [ 83 ] proposes that potentially traumatic stressors, such as caring for an individual diagnosed with cancer, cause a disruption in one’s worldview triggering attempts to make meaning in response to the stressor. Cognitive disruptions also lead to distress, which in turn can act as a catalyst for post-traumatic growth (PTG). Studies have found that caregivers of people with advanced cancer and early-stage breast cancer experience PTG in relation to their caregiving role [ 84 , 85 ], and that PTG was positively associated with greater social support and perceived hope [ 86 ]. Additional research is needed to understand how the challenging UGIC caregiver role may facilitate growth and help the caregiver adjust to their role.
The current systematic review has several strengths. Firstly, it followed an internationally recognised methodology (JBI) for the conduct of qualitative systematic reviews. This helped ensure methodological approach rigour and subsequently, confidence in findings should they be used to inform policy and practice. There are however several limitations. Although studies in the review are generally of good quality, only 19 studies were identified. Indeed, the UK Less Survivable Cancers Taskforce [ 87 ] advocates for more research focused on cancers with low life expectancy, two-thirds of which are UGICs. This lack of research into UGICs extends to the evidence on caregivers. Synthesised findings are therefore based on a small number of studies, largely conducted in the US and Denmark. Within the studies, caregivers of individuals with oesophageal and pancreatic cancer were well represented. However, there were a dearth of studies focused on caregivers’ experiences with gallbladder, or stomach cancer, alongside multiple studies exploring caregivers’ experiences related to dysphagia and malabsorption but fewer exploring jaundice. Therefore, more primary qualitative research is necessary to understand experiences of all UGIC caregiver populations.
Of relevance for clinical practice was the finding that caregivers often felt excluded in medical settings, increasing caregiver burden. Caregivers should be seen as co-clients along with patients in the medical setting. This is very much in line with the priorities of care within palliative healthcare settings. Since the palliative care approach seeks to addresses the physical, psychological, cultural, social, and spiritual needs [ 88 ] of both individuals with life-limiting and chronic illnesses like cancer and their support networks, early referral to palliative care services could be particularly beneficial for caregivers as their needs are formally and expertly acknowledged and thus help alleviate the burden identified for informal caregivers in this study.
HCPs have an opportunity to give caregivers reliable, specific, and up-to-date information, pitched at the right level to reassure but not overwhelm. Morris and Thomas [ 89 ] mirror this suggestion and highlight its importance, as there is potential for tension in information exchange due to HCP’s lack of formal acknowledgement of caregivers. Clinical guidance and policy could be updated to include recognition of caregivers as co-clients, and with caregiver training, could formally be part of the patient support team. This could help meet the caregivers’ needs, especially post-diagnosis. On an institutional level, caregivers may be more recognised within their role if acknowledged formally, for example in NICE [ 1 ] guidelines for UGICs. In understanding the considerable role caregivers undertake supporting the care of UGIC patients outside of the healthcare system, policymakers and HCPs need to improve support for caregivers which will in turn reduce the burden on health services.
The aim of this qualitative systematic review was to synthesize evidence about the experiences of UGIC caregivers and has found that caregivers face significant challenges leading to caregiver burden which negatively impacts adjustment. Due to the nature of UGICs, caregivers experienced unique challenges such as how best to manage disruptions to mealtimes and how to monitor surrogate markers of patient health, such as weight. UGICs are a medically complex and evolving chronic condition and caregivers struggle to gain information. This review found that caregiver burden was impacted by feeling excluded in medical settings which could be improved with better communication between HCPs, patients, and their caregivers. There is a lack of data relating to the experiences of certain UGIC caregivers (e.g., gallbladder, stomach) in comparison to others (e.g., oesophageal), as well as a lack of understanding on how to manage the impact of caregiving for these types of cancer, thus providing directions for future research.
No datasets were generated or analysed during the current study.
Gastrointestinal tract (upper). cancers - recognition and referral | Health topics A to Z | CKS |NICE. https://cks.nice.org.uk/topics/gastrointestinal-tract-upper-cancers-recognition-referral/2022 . Accessed 25 Aug 2022.
Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F. Global cancer observatory: cancer today. Lyon, France: International Agency for Research on Cancer (2020). https://gco.iarc.fr/today . Accessed 1 Sep 2021.
Xie Y, Shi L, He X, Luo Y. Gastrointestinal cancers in China, the USA, and Europe. Gastroenterol Rep. 2021;9(2):91–104.
Google Scholar
Gastrointestinal Cancers Global Burden Expected to Rise. National Cancer Institute. 2020. https://dceg.cancer.gov/news-events/news/2020/global-burden-gastro . Accessed 25 Aug 2022.
Veitch AM, Uedo N, Yao K, East JE. Optimizing early upper gastrointestinal cancer detection at endoscopy. Nat Reviews Gastroenterol Hepatol. 2015;12(11):660–7.
Vedeld HM, Goel A, Lind GE. Epigenetic biomarkers in gastrointestinal cancers: the current state and clinical perspectives. InSeminars in cancer biology 2018 Aug 1 (Vol. 51, pp. 36–49). Academic.
Hong L, Huang YX, Zhuang QY, Zhang XQ, Tang LR, Du KX, Lin XY, Zheng BH, Cai SL, Wu JX, Li JL. Survival benefit of re-irradiation in esophageal cancer patients with locoregional recurrence: a propensity score-matched analysis. Radiat Oncol. 2018;13(1):1–9.
CAS Google Scholar
Lee S, Kang TW, Song KD, Lee MW, Rhim H, Lim HK, Kim SY, Sinn DH, Kim JM, Kim K, Ha SY. Effect of microvascular invasion risk on early recurrence of hepatocellular carcinoma after surgery and radiofrequency ablation. Ann Surg. 2021;273(3):564–71.
PubMed Google Scholar
Sakamoto H, Attiyeh MA, Gerold JM, Makohon-Moore AP, Hayashi A, Hong J, Kappagantula R, Zhang L, Melchor JP, Reiter JG, Heyde A. The evolutionary origins of recurrent pancreatic CancerOrigins of recurrent pancreatic cancer. Cancer Discov. 2020;10(6):792–805.
CAS PubMed PubMed Central Google Scholar
Peery AF, Crockett SD, Murphy CC, Lund JL, Dellon ES, Williams JL… Sandler, R. S. Burden and cost of gastrointestinal, liver, and pancreatic diseases in the United States: update 2018. Gastroenterology. 2019;156(1):254–72. Study 2.
Peery AF, Crockett SD, Murphy CC, Lund JL, Dellon ES, Williams JL, Jensen ET, Shaheen NJ, Barritt AS, Lieber SR, Kochar B. Burden and cost of gastrointestinal, liver, and pancreatic diseases in the United States: update 2018. Gastroenterology. 2019;156(1):254–72.
Valentino T, Paiva B, Oliveira M, Hui D, Paiva C. Factors associated with palliative care referral among patients with advanced cancers: a retrospective analysis of a large Brazilian cohort. Support Care Cancer. 2018;26:1933–41.
Hudson P, Remedios C, Thomas K. A systematic review of psychosocial interventions for family carers of palliative care patients. BMC Palliat Care. 2010;9:17–17.
PubMed PubMed Central Google Scholar
Khan NN, Maharaj A, Evans S, Pilgrim C, Zalcberg J, Brown W, Cashin P, Croagh D, Michael N, Shapiro J, White K. A qualitative investigation of the supportive care experiences of people living with pancreatic and oesophagogastric cancer. BMC Health Serv Res. 2022;22(1):1–1.
Cencioni C, Trestini I, Piro G, Bria E, Tortora G, Carbone C, Spallotta F. Gastrointestinal cancer patient nutritional management: from specific needs to novel epigenetic dietary approaches. Nutrients. 2022;14(8):1542.
Given BA, Given CW, Sherwood PR. Family and caregiver needs over the course of the cancer trajectory. J Support Oncol. 2012;10:57–64. https://doi.org/10.1016/j.suponc.2011.10.003
Article PubMed Google Scholar
Kim Y, Baek W. Caring experiences of family caregivers of patients with pancreatic cancer: an integrative literature review. Support Care Cancer. 2022;7:1–0.
McCorry NK, Dempster M, Clarke C, Doyle R. Adjusting to life after esophagectomy: the experience of survivors and carers. Qual Health Res. 2009;19:1485–94. https://doi.org/10.1177/1049732309348366
Bozzetti F, Braga M, Gianotti L, Gavazzi C, Mariani L. Postoperative enteral versus parenteral nutrition in malnourished patients with gastrointestinal cancer: a randomised multicentre trial. Lancet. 2001;358(9292):1487–92.
CAS PubMed Google Scholar
Laursen L, Schønau MN, Bergenholtz HM, Siemsen M, Christensen M, Missel M. Table in the corner: a qualitative study of life situation and perspectives of the everyday lives of oesophageal cancer patients in palliative care. BMC Palliat care. 2019;18(1):1–0.
Cooper C, Burden ST, Molassiotis A. An explorative study of the views and experiences of food and weight loss in patients with operable pancreatic cancer perioperatively and following surgical intervention. Support Care Cancer. 2015;23(4):1025–33.
Dempster M, McCorry NK, Brennan E, Donnelly M, Murray LJ, Johnston BT. Psychological distress among family carers of oesophageal cancer survivors: the role of illness cognitions and coping. Psycho-oncology. 2011;20(7):698–705.
Graham L, Dempster M, McCorry NK, Donnelly M, Johnston BT. Change in psychological distress in longer-term oesophageal cancer carers: are clusters of illness perception change a useful determinant? Psycho‐Oncology. 2016;25(6):663–9.
Penner JL, McClement SE. Using phenomenology to examine the experiences of family caregivers of patients with advanced head and neck cancer: reflections of a novice researcher. Int J Qualitative Methods. 2008;7:92–101. https://doi.org/10.1177/160940690800700206
Article Google Scholar
Munn Z, Moola S, Riitano D, Lisy K. The development of a critical appraisal tool for use in systematic reviews addressing questions of prevalence. Int J Health Policy Manage. 2014;3(3):123.
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. https://doi.org/10.1136/bmj.n71
Article PubMed PubMed Central Google Scholar
Clarivate analytics. endnote (version 7.7.1). Philadelphia, USA. https://endnote.com Accessed 25 Aug 2022.
Mourad Ouzzani H, Hammady Z, Fedorowicz, Ahmed Elmagarmid. Rayyan — a web and mobile app for systematic reviews. Syst Reviews. 2016;5:210. https://doi.org/10.1186/s13643-016-0384-4
Joanna Briggs Institute. Joanna Briggs Institute critical appraisal checklist for studies reporting prevalence data. Adelaide: Joanna Briggs Institute; 2011.
Hodgson T. Oesophageal cancer: experiences of patients and their partners. Br J Nurs. 2006;15(21):1157–60.
LaDonna K, Taylor T, Lingard L. Why open-ended survey questions are unlikely to support rigorous qualitative insights. Acad Medicine: J Association Am Med Colleges. 2017;93(3):347–9.
Joanna Briggs Institute. Joanna Briggs Institute reviewers’ manual: 2014 edition. Australia: The Joanna Briggs Institute. 2014:88–91.
Lockwood C, Munn Z, Porritt K. Qualitative research synthesis: methodological guidance for systematic reviewers utilizing meta-aggregation. JBI Evid Implement. 2015;13(3):179–87.
Munn Z, Porritt K, Lockwood C, Aromataris E, Pearson A. Establishing confidence in the output of qualitative research synthesis: the ConQual approach. BMC Med Res Methodol. 2014;14(1):1–7.
Sherman DW, McGuire DB, Free D, Cheon JY. A pilot study of the experience of family caregivers of patients with advanced pancreatic cancer using a mixed methods approach. J Pain Symptom Manag. 2014;48(3):385–99.
Winterling J, Wasteson E, Glimelius B, Sjödén PO, Nordin K. Substantial changes in life: perceptions in patients with newly diagnosed advanced cancer and their spouses. Cancer Nurs. 2004;27:381–8.
Hansen L, Rosenkranz SJ, Wherity K, Sasaki A. Living with hepatocellular carcinoma near the end of life: family caregivers’ perspectives. In Oncology nursing forum 2017 Sep 1 (Vol. 44, No. 5).
Nolan MT, Hodgin MB, Olsen SJ, Coleman J. Spiritual issues of family members in a pancreatic cancer chat room. In Oncology Nursing Forum 2006 Mar 1 (Vol. 33, No. 2, p. 239). Oncology Nursing Society.
Padron A. Dyadic relationships among sense of mastery, cancer-related distress, and cortisol in patients and caregivers impacted by abdominal and pelvic malignancies. In University of Florida. 2018.
Petrin K, Bowen DJ, Alfano CM, Bennett R. Adjusting to pancreatic cancer: perspectives from first-degree relatives. Palliat Support Care. 2009;7(3):281–8.
Wong SS, George TJ, Godfrey M, Le J, Pereira DB. Using photography to explore psychological distress in patients with pancreatic cancer and their caregivers: a qualitative study. Support Care Cancer. 2019;27(1):321–8.
Larsen LS, Blix BH, Hamran T. Family caregivers’ involvement in decision-making processes regarding admission of persons with dementia to nursing homes. Dementia. 2020;19(6):2038–55.
Gerhardt S, Dengsø KE, Herling S, Thomsen T. From bystander to enlisted carer–a qualitative study of the experiences of caregivers of patients attending follow-up after curative treatment for cancers in the pancreas, duodenum and bile duct. Eur J Oncol Nurs. 2020;44:101717.
Larsen MK, Birkelund R, Mortensen MB, Schultz H. Being a relative on the sideline to the patient with oesophageal cancer: a qualitative study across the treatment course. Scand J Caring Sci. 2021;35(1):277–86.
Shaw J, Harrison J, Young J, Butow P, Sandroussi C, Martin D, Solomon M. Coping with newly diagnosed upper gastrointestinal cancer: a longitudinal qualitative study of family caregivers’ role perception and supportive care needs. Support Care Cancer. 2013;21(3):749–56.
Gooden HM, White KJ. Pancreatic cancer and supportive care—pancreatic exocrine insufficiency negatively impacts on quality of life. Support Care Cancer. 2013;21(7):1835–41.
Andreassen S, Randers I, Näslund E, Stockeld D, Mattiasson AC. Family members’ experiences, information needs and information seeking in relation to living with a patient with oesophageal cancer. Eur J Cancer Care. 2005;14(5):426–34.
Morowatisharifabad MA, Gerayllo S, Jouybari L, Amirbeigy MK, Fallahzadeh H. Concerns and fear of esophageal cancer in relatives of patients with cancer: a qualitative study. J Gastrointest cancer. 2020;51(3):957–64.
Yi M, Kahn D. Experience of gastric cancer survivors and their spouses in Korea: secondary analysis. J Korean Acad Nurs. 2004;34(4):625–35.
Morowatisharifabad MA, Gerayllo S, Jouybari L, Amirbeigy MK, Fallahzadeh H. Perceived threats toward esophageal cancer among immediate relatives of sufferers: a qualitative study. J Gastrointest Cancer. 2021;52:643–50. https://doi.org/10.1007/s12029-020-00422-y
Shih WM, Hsiao PJ, Chen ML, Lin MH. Experiences of family of patient with newly diagnosed advanced terminal stage hepatocellular cancer. Asian Pac J Cancer Prev. 2013;14(8):4655–60.
James Lind, Alliance. 2021. https://www.jla.nihr.ac.uk . Accessed 1 Sep 2021.
Girgis A, Lambert S. Caregivers of cancer survivors: the state of the field. In Cancer Forum 2009 Nov (Vol. 33, No. 3, pp. 168–171).
Wang T, Molassiotis A, Chung BP, Tan JY. Unmet care needs of advanced cancer patients and their informal caregivers: a systematic review. BMC Palliat care. 2018;17(1):1–29.
Cancer Caring Coping. 2021. https://www.qub.ac.uk/sites/CancerCaringCoping . Accessed 1 Sep 2021.
Santin O, McShane T, Hudson P, Prue G. Using a six-step co‐design model to develop and test a peer‐led web‐based resource (PLWR) to support informal carers of cancer patients. Psycho‐oncology. 2019;28(3):518–24.
Blazeby JM, Macefield R, Blencowe NS, Jacobs M, McNair AG, Sprangers M, Brookes ST, Avery KN, Blazeby JM, Blencowe NS, Brookes ST. Core information set for oesophageal cancer surgery. J Br Surg. 2015;102(8):936–43.
Jacobs M, Henselmans I, Macefield RC, Blencowe NS, Smets EM, de Haes JC, Sprangers MA, Blazeby JM, van Berge Henegouwen MI. Delphi survey to identify topics to be addressed at the initial follow-up consultation after oesophageal cancer surgery. J Br Surg. 2014;101(13):1692–701.
Reblin M, Ketcher D, Vadaparampil ST. Care for the cancer caregiver: a qualitative study of facilitators and barriers to caregiver integration and support. J Cancer Educ. 2021;30:1–7.
Pape E, Decoene E, Debrauwere M, Van Nieuwenhove Y, Pattyn P, Feryn T, Pattyn PR, Verhaeghe S, Van Hecke A, Vandecandelaere P, Desnouck S. Experiences and needs of partners as informal caregivers of patients with major low anterior resection syndrome: a qualitative study. Eur J Oncol Nurs. 2022;58:102143.
Dacre J, Francis R, Appleby J, Charlesworth A, Peckham S, Ahmed S, Brown J, Dickson J, Morris N, Patel M. Expert panel: evaluation of the Government’s commitments in the area of cancer services in England.
Taleghani F, Ehsani M, Farzi S, Farzi S, Adibi P, Moladoost A, Shahriari M, Tabakhan M. Nutritional challenges of gastric cancer patients from the perspectives of patients, family caregivers, and health professionals: a qualitative study. Support Care Cancer. 2021;29(7):3943–50.
Reece L, Hogan S, Allman-Farinelli M, Carey S. Oral nutrition interventions in patients undergoing gastrointestinal surgery for cancer: a systematic literature review. Support Care Cancer. 2020;28(12):5673–91.
Hanna L, Huggins CE, Furness K, Silvers MA, Savva J, Frawley H, Croagh D, Cashin P, Low L, Bauer J, Truby H. Effect of early and intensive nutrition care, delivered via telephone or mobile application, on quality of life in people with upper gastrointestinal cancer: study protocol of a randomised controlled trial. BMC Cancer. 2018;18(1):1–3.
Missel M, Hansen M, Jackson R, Siemsen M, Schønau MN. Re-embodying eating after surgery for oesophageal cancer: patients’ lived experiences of participating in an education and counselling nutritional intervention. J Clin Nurs. 2018;27(7–8):1420–30.
Dempster M, McCorry NK, Brennan E, Donnelly M, Murray LJ, Johnston BT. Illness perceptions among carer–survivor dyads are related to psychological distress among oesophageal cancer survivors. J Psychosom Res. 2011;70(5):432–9.
Deckx L, van den Akker M, Buntinx F. Risk factors for loneliness in patients with cancer: a systematic literature review and meta-analysis. Eur J Oncol Nurs. 2014;18(5):466–77.
Gray TF, Azizoddin DR, Nersesian PV. Loneliness among cancer caregivers: a narrative review. Palliat Support Care. 2020;18(3):359–67.
Beutel ME, Klein EM, Brähler E, Reiner I, Jünger C, Michal M, et al. Loneliness in the general population: prevalence, determinants and relations to mental health. BMC Psychiatry. 2017;17(1):97. pmid:28320380.
Holt-Lunstad J, Smith TB, Baker M, Harris T, Stephenson D. Loneliness and social isolation as risk factors for mortality: a meta-analytic review. Perspect Psychol Sci. 2015;10(2):227–37. pmid:25910392.
Velloze IG, Jester DJ, Jeste DV, Mausbach BT. Interventions to reduce loneliness in caregivers: an integrative review of the literature. Psychiatry Res. 2022;12:114508.
Haj Mohammad N, Walter AW, van Oijen MGH, et al. Burden of spousal caregivers of stage II and III esophageal cancer survivors 3 years after treatment with curative intent. Support Care Cancer. 2015;23:3589–98. https://doi.org/10.1007/s00520-015-2727-4
Article CAS PubMed PubMed Central Google Scholar
Langenberg SM, Reyners AK, Wymenga AN, Sieling GC, Veldhoven CM, van Herpen CM, Prins JB, van der Graaf WT. Caregivers of patients receiving long-term treatment with a tyrosine kinase inhibitor (TKI) for gastrointestinal stromal tumour (GIST): a cross-sectional assessment of their distress and burden. Acta Oncol. 2019;58(2):191–9.
Teixeira RJ, Applebaum AJ, Bhatia S, Brandão T. The impact of coping strategies of cancer caregivers on psychophysiological outcomes: an integrative review. Psychol Res Behav Manage. 2018;11:207.
Folkman S, Lazarus RS. Stress, appraisal, and coping. New York: Springer Publishing Company; 1984. p. 460.
Han Y, Hu D, Liu Y, Lu C, Luo Z, Zhao J, Lopez V, Mao J. Coping styles and social support among depressed Chinese family caregivers of patients with esophageal cancer. Eur J Oncol Nurs. 2014;18(6):571–7.
Rankin SR. Influence of coping styles on social support seeking among cancer patient family caregivers (Doctoral dissertation, Walden University).
Bowman KF, Rose JH, Radziewicz RM, O’Toole EE, Berila RA. Family caregiver engagement in a coping and communication support intervention tailored to advanced cancer patients and families. Cancer Nurs. 2009;32(1):73–81.
Baltes PB, Baltes MM, editors. Successful aging: perspectives from the behavioral sciences. Cambridge University Press; 1993 May. p. 28.
Toseland RW, Blanchard CG, McCallion P. A problem solving intervention for caregivers of cancer patients. Soc Sci Med. 1995;40(4):517–28.
McMillan SC, Small BJ, Weitzner M, Schonwetter R, Tittle M, Moody L, Haley WE. Impact of coping skills intervention with family caregivers of hospice patients with cancer: a randomized clinical trial. Cancer. 2006;106(1):214–22.
Li Q, Loke AY. The positive aspects of caregiving for cancer patients: a critical review of the literature and directions for future research. Psycho-oncology. 2013;22(11):2399–407.
Tedeschi RG, Calhoun LG. Trauma and transformation. Sage; 1995 Jun. p. 20.
Liu Y, Li Y, Chen L, Li Y, Qi W, Yu L. Relationships between family resilience and posttraumatic growth in breast cancer survivors and caregiver burden. Psycho-oncology. 2018;27(4):1284–90.
Moore AM, Gamblin TC, Geller DA, Youssef MN, Hoffman KE, Gemmell L, Likumahuwa SM, Bovbjerg DH, Marsland A, Steel JL. A prospective study of posttraumatic growth as assessed by self-report and family caregiver in the context of advanced cancer. Psycho‐oncology. 2011;20(5):479–87.
Nouzari R, Najafi SS, Momennasab M. Post-traumatic growth among family caregivers of cancer patients and its association with social support and hope. Int J Community Based Nurs Midwifery. 2019;7(4):319.
Less Survivable Cancers Taskforce.org.uk. London: Principle Consulting. https://lesssurvivablecancers.org.uk . Accessed 30 December 2021.
Dy S, Isenberg S, Hamayel N. Palliative care for cancer survivors. Med Clin N Am. 2017;101(6):1181–96.
Morris SM, Thomas C. The need to know: informal carers and information 1. Eur J Cancer Care. 2002;11(3):183–7.
Download references
Not applicable.
Authors and affiliations.
School of Psychology, Queen’s University Belfast, University Road, Belfast, BT7 1NN, UK
Melinda Furtado, Dawn Davis, Jenny M. Groarke & Lisa Graham-Wisener
School of Psychology, University of Galway, University Road, Galway, Ireland
Jenny M. Groarke
You can also search for this author in PubMed Google Scholar
M.F., D.D. wrote the main manuscript text with supervision/assistance from J.M.G and L G-W . All authors reviewed the manuscript.
Correspondence to Melinda Furtado .
Ethics approval and consent to participate, consent for publication, competing interests.
The authors declare no competing interests.
Publisher’s note.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Below is the link to the electronic supplementary material.
Search Strategy
Findings illustrations table
ConQual table
Characteristics of studies
Methodological assessment
Meta-synthesis
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ . The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/ ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
Reprints and permissions
Cite this article.
Furtado, M., Davis, D., Groarke, J.M. et al. Experiences of informal caregivers supporting individuals with upper gastrointestinal cancers: a systematic review. BMC Health Serv Res 24 , 932 (2024). https://doi.org/10.1186/s12913-024-11306-3
Download citation
Received : 20 June 2024
Accepted : 10 July 2024
Published : 14 August 2024
DOI : https://doi.org/10.1186/s12913-024-11306-3
Anyone you share the following link with will be able to read this content:
Sorry, a shareable link is not currently available for this article.
Provided by the Springer Nature SharedIt content-sharing initiative
ISSN: 1472-6963
Published on 14.8.2024 in Vol 26 (2024)
This is a member publication of University of Toronto
Authors of this article:
1 Krembil Centre for Health Management and Leadership, Schulich School of Business, York University, Toronto, ON, Canada
2 Institute for Health Policy, Management and Evaluation, Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada
3 Gustavson School of Business, University of Victoria, Victoria, ON, Canada
4 College of Business, Florida International University, Florida, FL, United States
5 Department of Management, Cleveland State University, Cleveland, OH, United States
6 Department of Health Services Administration, School of Health Professions, University of Alabama Birmingham, Birmingham, OH, United States
Abi Sriharan, MSc, DPhil
Krembil Centre for Health Management and Leadership
Schulich School of Business
York University
MB Room G315
4700 Keele St
Toronto, ON, M3J 1P3
Phone: 1 3658855898
Email: [email protected]
Background: The leaders of health care organizations are grappling with rising expenses and surging demands for health services. In response, they are increasingly embracing artificial intelligence (AI) technologies to improve patient care delivery, alleviate operational burdens, and efficiently improve health care safety and quality.
Objective: In this paper, we map the current literature and synthesize insights on the role of leadership in driving AI transformation within health care organizations.
Methods: We conducted a comprehensive search across several databases, including MEDLINE (via Ovid), PsycINFO (via Ovid), CINAHL (via EBSCO), Business Source Premier (via EBSCO), and Canadian Business & Current Affairs (via ProQuest), spanning articles published from 2015 to June 2023 discussing AI transformation within the health care sector. Specifically, we focused on empirical studies with a particular emphasis on leadership. We used an inductive, thematic analysis approach to qualitatively map the evidence. The findings were reported in accordance with the PRISMA-ScR (Preferred Reporting Items for Systematic Reviews and Meta-Analysis extension for Scoping Reviews) guidelines.
Results: A comprehensive review of 2813 unique abstracts led to the retrieval of 97 full-text articles, with 22 included for detailed assessment. Our literature mapping reveals that successful AI integration within healthcare organizations requires leadership engagement across technological, strategic, operational, and organizational domains. Leaders must demonstrate a blend of technical expertise, adaptive strategies, and strong interpersonal skills to navigate the dynamic healthcare landscape shaped by complex regulatory, technological, and organizational factors.
Conclusions: In conclusion, leading AI transformation in healthcare requires a multidimensional approach, with leadership across technological, strategic, operational, and organizational domains. Organizations should implement a comprehensive leadership development strategy, including targeted training and cross-functional collaboration, to equip leaders with the skills needed for AI integration. Additionally, when upskilling or recruiting AI talent, priority should be given to individuals with a strong mix of technical expertise, adaptive capacity, and interpersonal acumen, enabling them to navigate the unique complexities of the healthcare environment.
Artificial intelligence in health care: overview.
Artificial intelligence (AI) technologies have gained significant momentum in health care, presenting a transformative potential across clinical processes, operational efficiency, decision-making, and workforce optimization [ 1 - 3 ]. The global AI market is projected to shift from US $14.6 billion in 2023 to a formidable estimate of US $102.7 billion by 2028 [ 4 ], unveiling a dynamic transformation of unprecedented scale. This investment, coupled with the engagement of nontraditional health care players such as Microsoft, Google, and Amazon and the convergence of technological prowess and health care innovation signaled by generative AI, will place the trajectory of AI in health care in a state of exponential growth [ 5 ].
Current investments in health care AI predominantly center on bolstering data capacity, enhancing computational power, and advancing methodological innovations in AI. This includes developing and testing AI models and algorithms tailored for precision medicine, drug discovery, clinical decision-making support, public health surveillance, operational optimization, and process improvement [ 6 , 7 ]. Notably, between August 2022 and July 2023, there were over 150 submissions of drug and biological applications incorporating AI and machine learning components to the US Food and Drug Administration, encompassing a wide array of therapeutic domains and developmental stages [ 8 ].
Yet the seamless integration of AI technologies into health care organizational settings presents a multifaceted challenge for health care leaders. This challenge arises from several factors, including the complex nature of AI models, the rapid pace of technological advancement, the imperative of regulatory adherence, ethical concerns surrounding data security and privacy, the risk of perpetuating racial and ethnic biases in data, the necessity of prioritizing human-centric approaches to patient care, and the intricate clinical workflows that must be navigated [ 9 - 15 ]. Furthermore, health care leaders are facing critical and intricate strategic decisions. They must discern which AI solutions merit investment while weighing the merits of in-house development against strategic partnerships with external vendors. Selecting the right vendors and defining the scope of collaboration is pivotal, as is devising a sustainable funding strategy to support both initial development and continuous innovation. Furthermore, they must confront the crucial question of whether to bring in new AI talent or bolster the expertise of their current workforce through upskilling. Each of these decisions will shape the trajectory of health care organizations as they navigate this transformative era. A report by Bain in 2023 revealed that although 75% of surveyed health system executives recognize AI’s potential to reshape the health care industry, only 6% have established concrete strategies related to AI [ 16 ].
The lack of strategy and strategic failures in AI integration not only have financial consequences for organizations but also erode trust among patients, providers, and organizations [ 17 ]. A prominent example is the collaboration between MD Anderson and IBM Watson, aimed at leveraging IBM Watson’s cognitive capabilities to combat cancer. This ambitious endeavor, however, incurred a substantial financial toll of over US $62 million for MD Anderson because of setbacks in clinical implementation [ 18 ].
Despite a growing body of AI literature, including toolkits such as Canada Health Infoway’s “Toolkit for AI Implementers” [ 19 ] and guidance from the US Department of Health and Human Services’ AI Task Force [ 20 ] and the UK National Strategy for AI in Health and Social Care [ 21 ], there is still insufficient scholarly attention on how leadership behavior guides AI transformation in health care. Existing reviews focus on AI in medical education [ 22 , 23 ], workforce impact [ 24 ], applications in clinical medicine [ 13 , 25 ], barriers to implementation [ 26 , 27 ], and ethical considerations [ 28 , 29 ]. However, no systematic mapping of empirical literature has clarified our understanding of leadership or identified gaps in research. Understanding leadership behavior is crucial for health care organizations considering AI because effective leadership shapes the strategic direction, adoption, and successful implementation of AI technologies.
To address this research gap and to establish a future research agenda this scoping review study aims to address two primary questions: (1) What role does leadership play in AI transformation within health care? and (2) What approaches can health care organizations use to empower their leaders in facilitating AI transformation?
This review follows scoping review methodology [ 30 ] to identify and analyze the current literature and report results following the PRISMA-ScR (Preferred Reporting Items for Systematic Reviews and Meta-Analyses for Scoping Reviews; Multimedia Appendix 1 ) guidelines [ 31 ].
In the context of this study, AI refers to combination of machine learning algorithms, large language models, robotics, and natural language processing systems designed to mimic human cognitive functions, enabling machines to perform tasks autonomously or with minimal human intervention.
AI transformation refers to the systematic changes in clinical, operational, or organizational processes and business models due to the introduction of AI systems to optimize decision-making, automate tasks, improve patient outcomes, and drive organizational change. This involves identifying opportunities for AI-related innovation, integrating them into processes, and developing strategies to operationalize implementation while ensuring organizational readiness. This is essential for getting health care organizations AI-ready.
Further, in the context of this study, drawing from seminal management and leadership theories, we view leadership as an effective management practice [ 32 ]. However, we recognize that leadership roles in health care occur at the clinical, organizational, and systems levels of health systems. At the clinical level, leadership emerges through health care professionals who steer patient care and treatment decisions. At the organizational level, leadership involves middle managers such as unit heads and division leaders guiding health care institutions, administrative units, and personnel toward their goals. At the systems level, leadership encapsulates C-suite leadership responsible for navigating regulatory complexities and organizational and structural silos within complex health systems.
The following inclusion and exclusion criteria guided our study: (1) focused on AI in health care, (2) contained an evaluation of leadership, (3) were written in English, (4) were published in a peer-reviewed journal, (5) published between January 2015 and June 2023, and (6) used research.
We adopted comprehensive search strategies for the following electronic databases focused on the health care and business literature: MEDLINE (via Ovid), PsycINFO (via Ovid), CINAHL (via EBSCO), Business Source Premier (via EBSCO), and Canadian Business & Current Affairs (via ProQuest). An academic librarian developed these search strategies with input from the research team. We initially conducted the search in Ovid MEDLINE. We then reviewed our search results using the Peer Review of Electronic Search Strategies tool [ 33 ], a checklist for comparing, among other things, the types of errors found in articles and the relative fit of articles to the research question before translating the search strategy into other databases using their command language. Our search was limited to articles published from January 2015 (from the first use of AI-powered chatbots in health care [ 34 ] to June 2023. We then ran searches in 4 databases and exported the final search results into the EndNote reference management software (Clarivate), and we removed duplicate articles manually. To capture any papers that may have been missed during the search process, we did forward and reverse citation searches of systematic review articles related to AI [ 35 ]. However, we did not find any additional articles that met our criteria. Finally, we imported search results to Covidence (Veritas Health Innovation), a review management software for abstract and title screening, full-text screening, and data charting.
To minimize selection bias, 2 independent screeners reviewed the titles and abstracts of articles identified via the search against the eligibility criteria using Covidence. We identified articles that met the eligibility criteria for a comprehensive full-text screening. Two independent reviewers then evaluated the full texts against the eligibility criteria using Covidence. In discrepancies between the reviewers, a third reviewer served as the consensus reviewer and used Covidence to resolve conflicts between reviewer 1 and reviewer 2. Following the exclusion of irrelevant articles, we used a predefined data extraction form aligned with our research objectives and guiding questions for systematic data collection. Data extraction categories included data on study characteristics (eg, citations and country); methods (eg, aim, data collection methods, and methodological quality); study context (eg, leadership role, ie, clinical, organizational, or systems); leadership practices (ie, behavior, enablers, and barriers to leadership success); results (ie, main results and author conclusion); and an open-ended reviewer note (ie, capture any relevant information that might aid in the data analysis stage). The data abstraction form was piloted on a random sample of 4 included articles and modified based on feedback from the team. Full data abstraction began only after sufficient agreement had been obtained. Two reviewers independently extracted the data using Covidence, and a third reviewer assessed the data extraction for quality and consensus. Three authors then held a group discussion to resolve any conflicts.
The focus of scoping reviews is to provide a comprehensive overview of the available literature, identifying the extent, range, and nature of research on a particular topic rather than assessing the methodological quality of individual studies [ 35 ]. Therefore, we did not perform risk of bias evaluations on the articles included in compliance with the guidelines for scoping reviews.
Our data analysis was guided by a thematic analysis process [ 36 ]. To ensure the accuracy of the emerging themes, we conducted our analysis collaboratively in reviewer pairs [ 35 ].
We initially analyzed the extracted data using an open-coding method guided by our research questions. Subsequently, we grouped the codes into categories based on the emerging patterns in the data, which we then synthesized into leadership functional domains, capacities, and context.
In the context of our analysis, functional domains refer to distinct areas of responsibility that a leader must effectively manage a task or a role. Capacity, on the other hand, pertains to the abilities—skills, competencies, or behaviors—that a leader must demonstrate to achieve desired goals. Context refers to the environment, conditions, and situational factors that shape and influence leadership practices and decisions.
As described in Figure 1 , the original searches generated 3541 articles published from January 2015 to June 2023. After removing 728 duplicate articles in EndNote, 2813 unique articles were uploaded to Covidence. A total of 2813 relevant studies were then screened using Covidence using the articles’ titles and abstracts. We determined that 97 articles met the criteria for a full-text review for eligibility screening. Within these 97 articles, 75 were excluded as they were opinion articles or commentaries without objective data. After conducting the full-text screening, we found that 22 articles met the final inclusion criteria.
Of the 22 studies identified for final inclusion in our review, 12 involved qualitative methods [ 37 - 48 ] such as interviews and case studies, whereas 4 studies involved mixed methods research [ 49 - 52 ] with a qualitative and quantitative strand. There were 3 narrative reports [ 53 - 55 ] based on document synthesis, and 3 studies involved quantitative methods [ 56 - 58 ] such as surveys. These articles focused on clinical, organizational, and systems leadership and came from Canada, China, Finland, Saudi Arabia, Sweden, the Netherlands, the United Kingdom, and the United States. The included papers addressed a broad array of AI applications in health care, including studies focused on improving workflows, quality of care, patient safety, resource optimization, and patient experience. From a clinical domain, researchers focused on primary care, health care systems, radiology, or global health. From a population perspective, the papers covered leadership from the perspective of primary care physicians, radiologists, nurses, nurse managers, public health professionals, global health professionals, health care entrepreneurs, and health care leaders. Table 1 provides a summary of study characteristics.
Reference | Country | Study context | Leadership level | Theory or framework guiding the research | Study type |
Barbour et al [ ] | United States | Emergency medicine or medical education | Systems | N/A | Qualitative |
Darcel et al [ ] | Canada | Primary care | Clinical or systems | Sociotechnological framework | Qualitative |
Dicuonzo et al [ ] | Canada | Hospital | Organizational or systems | Comprehensive health = technology assessment framework | Qualitative |
Dixit et al [ ] | Canada | Health care system | Clinical, organizational, or systems | N/A | Narrative report |
Ergin et al [ ] | Turkey | Nursing | Clinical, organizational, or nursing | N/A | Quantitative |
Galsgaard et al [ ] | Denmark | Radiology | Clinical | Self-efficacy and professional identity | Narrative report |
Ganapathi and Duggal [ ] | United Kingdom | Physicians | Clinical | N/A | Qualitative |
Gillan [ ] | Canada | Radiation medicine and medical imaging technology | Systems or clinical | Normalization Process Theory (NPT) | Qualitative |
Hakim et al [ ] | Canada | Health care system | Systems or organizational | Health Information and Management Systems Society Adoption Model for Analytics Maturity (AMAM) | Mixed method |
Henriksen and Bechmann [ ] | Belgium | Technology development | Organizational | Work process and practice-oriented focus | Qualitative |
Laukka et al [ ] | Finland | Nursing | Organizational, clinical, or nursing | N/A | Qualitative |
Li et al [ ] | China | Nursing | Organizational, clinical, or nursing | Job Demand-Control-Support (JDCS) model | Quantitative |
Morley et al [ ] | United Kingdom | Global health | Systems or global health | N/A | Mixed method |
Nasseef et al [ ] | Saudi Arabia | Health care organization | Systems or public health | Cognitive Fit Theory (CFT) | Quantitative |
Olaye and Seixas [ ] | United States | Health care startups | Systems or digital health startup | N/A | Qualitative |
Petersson et al [ ] | Sweden | Health care system | Organizational or systems | N/A | Qualitative |
Ronquillo et al [ ] | International | Nursing | Systems, clinical, or nursing | N/A | Qualitative |
Sawers et al [ ] | International | Sustainable development goals—eye health | Systems or global health | N/A | Narrative review |
Strohm et al [ ] | Netherland | Radiology | Clinical | Nonadoption, Abandonment, Scale-up, Spread, and Sustainability (NASSS) Framework for new medical technologies in health care organizations. | Qualitative |
Upshaw et al [ ] | Canada | Primary care | Systems | Sittig and Singh’s model for studying Health Information Technology (HIT) in complex adaptive health systems | Qualitative |
Willis et al [ ] | United Kingdom | Primary care | Clinical | O*NET classification of occupational tasks | Mixed method |
Yang et al [ ] | China | Hospital | Organizational or systems | Technology-Organization-Environment (TOE) Framework | Mixed method |
a N/A: not applicable.
We mapped the themes from the included studies across 4 functional domains of leadership task responsibility—technological (AI innovation), strategic (vision and alignment), operational (process and oversight), and organizational (culture and work environment).
The technological functional domain garnered the most significant attention in the literature. The core themes that emerged under the technological domain primarily focused on applying subject matter expertise and AI technical skills to effectively identify AI opportunities, as well as to foster an innovation mindset to develop, tailor, and seamlessly implement AI-driven solutions to address key AI opportunities within health care organizations.
Within the strategic functional domain, the literature underscored the importance of change management and communication as strategic tools for consensus and collaboration related to the AI transformation process. Another core theme that emerged focused on the critical importance of integrating AI solutions into the existing clinical care processes. This strategic alignment is essential for getting support from the staff and ensuring smooth operations of patient care outcomes while embracing the potential of AI solutions. Although the significance of talent strategy related to the recruitment and retention of AI technical expertise within organizations was mentioned, it was not widely seen across the included papers.
Table 2 provides a summary of how the technological and strategic functional domains map across the papers and provides key themes that emerged with the domain area.
Reference | Functional domain | Key themes | Functional domain | Key themes | ||||||
Technological | Subject matter expertise | Technical skills | Innovation mindset | Strategic | Change | Communication | Alignment | |||
Barbour et al [ ] | ✓ | ✓ | ✓ | |||||||
Darcel et al [ ] | ✓ | ✓ | ✓ | ✓ | ||||||
Dicuonzo et al [ ] | ✓ | ✓ | ✓ | ✓ | ||||||
Dixit et al [ ] | ✓ | ✓ | ✓ | |||||||
Ergin et al [ ] | ✓ | ✓ | ✓ | |||||||
Galsgaard et al [ ] | ✓ | ✓ | ✓ | ✓ | ✓ | |||||
Ganapathi and Duggal [ ] | ✓ | ✓ | ✓ | ✓ | ✓ | |||||
Gillan [ ] | ✓ | ✓ | ✓ | ✓ | ||||||
Hakim et al [ ] | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ||||
Henriksen and Bechmann [ ] | ✓ | ✓ | ✓ | ✓ | ✓ | |||||
Laukka et al [ ] | ✓ | ✓ | ||||||||
Li et al [ ] | ✓ | ✓ | ✓ | ✓ | ||||||
Morley et al [ ] | ✓ | ✓ | ✓ | |||||||
Nasseef et al [ ] | ✓ | ✓ | ✓ | |||||||
Olaye and Seixas [ ] | ✓ | ✓ | ✓ | ✓ | ||||||
Petersson et al [ ] | ✓ | ✓ | ✓ | ✓ | ✓ | |||||
Ronquillo et al [ ] | ✓ | ✓ | ✓ | ✓ | ✓ | |||||
Sawers et al [ ] | ✓ | ✓ | ✓ | ✓ | ||||||
Strohm et al [ ] | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ||||
Upshaw et al [ ] | ✓ | ✓ | ✓ | |||||||
Willis et al [ ] | ✓ | ✓ | ✓ | ✓ | ✓ | |||||
Yang et al [ ] | ✓ | ✓ | ✓ | ✓ | ✓ |
Emerging evidence in the operational functional domain highlights leaders’ need to navigate ethical and risk management issues by establishing robust governance structures prioritizing patient data privacy and security while ethically integrating AI technologies within existing workflows. Additionally, the literature emphasizes that implementing AI in health care will require leaders to ensure new AI solutions comply with existing regulatory and control systems. The literature highlighted that leaders need to pay attention to process agility through continuous monitoring to ensure AI solutions can adapt to contextual changes.
Finally, the organizational functional domain emerges from the thematic analysis as a pivotal area for AI leadership. The literature emphasizes the importance of stakeholder engagement in building collaboration. Furthermore, it underscores the importance of decision makers’ sense-making to enhance their trust in AI opportunities and ensure that AI integration is supported by individuals across the organization. Further, the literature underscored the importance of organizational culture readiness to support physicians and nurses through protected time and incentive pay to engage, innovate, and adopt AI solutions. Table 3 provides a summary of how operational and organizational functional domains map across the papers.
Author | Functional domain | Key themes | Functional domain | Key themes | ||||||
Operational | Ethical and risk management | Regulatory compliance | Process agility | Organizational | Stakeholder engagement or collaboration | Trust and sense-making | Organizational culture and readiness | |||
Barbour et al [ ] | ||||||||||
Darcel et al [ ] | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ||||
Dicuonzo et al [ ] | ✓ | ✓ | ✓ | |||||||
Dixit et al [ ] | ✓ | ✓ | ✓ | |||||||
Ergin et al [ ] | ✓ | ✓ | ||||||||
Galsgaard et al [ ] | ✓ | ✓ | ||||||||
Ganapathi and Duggal [ ] | ✓ | ✓ | ✓ | |||||||
Gillan [ ] | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ||||
Hakim et al [ ] | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ||||
Henriksen and Bechmann [ ] | ✓ | ✓ | ✓ | |||||||
Laukka et al [ ] | ✓ | ✓ | ✓ | |||||||
Li et al [ ] | ✓ | ✓ | ||||||||
Morley et al [ ] | ✓ | ✓ | ✓ | ✓ | ✓ | |||||
Nasseef et al [ ] | ✓ | ✓ | ✓ | |||||||
Olaye and Seixas [ ] | ✓ | ✓ | ✓ | ✓ | ✓ | |||||
Petersson et al [ ] | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ||||
Ronquillo et al [ ] | ✓ | ✓ | ✓ | ✓ | ||||||
Sawers et al [ ] | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ||||
Strohm et al [ ] | ✓ | ✓ | ✓ | ✓ | ||||||
Upshaw et al [ ] | ✓ | ✓ | ||||||||
Willis et al [ ] | ✓ | ✓ | ||||||||
Yang et al [ ] | ✓ | ✓ | ✓ | ✓ | ✓ |
We categorized the themes related to skills and behaviors into 3 essential capacities that a leader must demonstrate to achieve desired goals—technical capacity, adaptive capacity, and interpersonal capacity. Technical capacity encompasses (1) AI literacy, (2) subject matter knowledge, (3) change leadership skills, and (4) innovation mindset to identify AI innovation opportunities. The interpersonal capacity involves several vital facets such as (1) the ability to foster partnerships among diverse stakeholders, (2) the ability to comprehend diverse stakeholder perspectives and deftly influence adoption, (3) the ability to build trust and collaboration, (4) self-awareness and humility to assemble teams with complementary skills, and (5) the integrity and accountability to embody ethical principles. The adaptive capacity encompasses (1) the foresight and sense-making abilities to discern emerging technologies and their implications within the health care sphere; (2) the agility to identify and capitalize on transformative opportunities, swiftly adapting and aligning strategies with evolving contexts; and (3) systems thinking to enable an understanding of how elements interconnect and how changes in 1 area can reverberate throughout the entire system.
The emerging themes from our review reveal that dynamic environmental and situational factors, including regulatory, technology, and organizational contexts, shape AI transformation within health care organizations. For instance, the regulatory context and frameworks related to health professions and health care organizations play a critical role in how AI can be integrated within the organizations. Similarly, the technology context such as the availability of AI technical talent, the retention of technical expertise, the dynamic nature of AI maturity, and the presence of incentives and technological resources for AI innovation or adoption will significantly influence a leader’s ability to effectively drive AI readiness. Finally, the organization context is a critical influence on leaders’ capacity for AI adoption and implementation. Organizations that promote and reward innovation and that have transparent communication practices shape leaders’ ability to pursue AI opportunities.
For the technological domain, the included papers discussed approaches such as upskilling clinical experts with the necessary AI technical skills and ensuring the presence of specialized experts, such as computer scientists, to enable the subject matter experts to develop, test, and seamlessly integrate AI solutions. Further, the papers discussed collaborative strategies such as clinicians and computer scientists working together to effectively identify AI opportunities and develop, adopt, and implement AI solutions in clinical or operational areas.
For the strategic domain, organizational support was essential in supporting leaders to assess and identify AI opportunities that strategically align with organizational priorities and develop strategies to ensure AI transformation garners support from key stakeholders within the complex regulatory and environmental contexts. The literature also highlighted the competition for AI talent in health care and emphasized the significance of talent retention strategies to preserve the organization’s AI technical expertise.
Then, in the operational domain, the emphasis was on establishing governance structures to continuously monitor data quality, patient privacy, and patient care experiences and assess the feasibility and financial implications of AI transformation. These governance structures ensure effective oversight and management of AI initiatives within health care organizations.
Finally, for the organizational domain, the focus was on the pivotal role of organizational culture in AI leadership. Leaders require organizational support to cultivate an environment that fosters innovation and actively incentivizes clinical leaders, such as physicians and nurses, through protected time and incentive pay to innovate and adopt AI solutions. Transparent decision-making processes related to AI solutions are essential cultural elements that build trust in AI systems and promote collaboration among the diverse stakeholders involved in AI transformation within health care organizations.
The purpose of a scoping review is not to draw definitive conclusions but to map the literature, identify emerging patterns, and develop critical propositions. As described in Figure 2 , analysis of current literature shows that leading organizations toward AI transformation requires multidimensional leadership. As such, health care organizations need to engage leaders in the technological, strategic, operational, and organizational domains to facilitate AI transformation in their organizations. Further, the reviewed papers suggest that individuals in AI-related leadership roles need to demonstrate (1) technical capacity to understand the technology and innovation opportunities, (2) adaptive capacity to respond to contextual changes, and (3) interpersonal capacity to navigate the human aspects of the AI transformation process effectively. Furthermore, our study illuminates that leaders in the AI-related leadership roles need to navigate regulatory context, the dynamic nature of changing technology context, and organization context.
Health care organizations are marked by multifaceted interdependencies among medical facilities, health care providers, patients, administrative units, technology, and the regulatory environment. Therefore, the leadership required for AI transformation—which includes identifying AI opportunities, implementing AI solutions, and achieving full-scale AI adaptation—is not a static role but a continuous and dynamic process. Effective leadership involves the capacity to continuously identify opportunities for AI transformation, influence the thoughts and actions of others, and navigate the complex dynamics of the health care setting and AI technology landscape simultaneously. However, the current literature has not fully articulated this multidimensionality, often focusing on leadership through a linear approach.
Further, multiple situational factors can shape AI transformation. First, the rapid growth of AI technologies introduces an element of uncertainty, making it challenging to anticipate the long-term impact and sustainability of specific AI solutions [ 6 ]. Second, AI implementation involves many stakeholders, from technical experts and domain specialists to clinicians, administrators, patients, vendors, and regulatory bodies. Each stakeholder group brings its unique perspectives, priorities, and control systems into the equation, necessitating leaders to navigate competing values, trade-offs, and paradoxes [ 27 ]. Third, once alignment is achieved, the integration of AI within an organization triggers a need for a cultural shift, altering work practices and decision-making processes [ 38 , 59 ]. Fourth, the effectiveness of AI solutions hinges on the availability of high-quality data for informed insights and decision-making. When implementing solutions originally developed within different contexts, local organizations must ensure data integrity and the solution’s adaptability to the organization’s unique context [ 18 ]. This challenge is compounded by emerging regulatory frameworks, which add a layer of complexity. Ensuring compliance and the responsible use of AI technologies has become a critical consideration [ 29 , 50 , 60 ]. Finally, introducing AI may provoke resistance from employees concerned about job displacement or disruptions to established workflows. This problem is further compounded when an organization transitions toward integrating multiple AI systems, as these changes can lead to periods of chaos and confusion [ 59 ].
Emerging key opinions and evidence from outside the health domain indicate that leaders must possess an understanding of data quality nuances, assess process risks, and manage AI as a new team member. Additionally, leaders should have a firm grasp of technology, articulate clear business objectives, define precise goals, uphold a long-term vision, prepare their teams for AI transformation, manage data resources effectively, and foster organizational collaboration [ 3 , 61 - 67 ].
Our findings on the leadership required for AI transformation in health care organizations reinforce this multidimensionality of leadership to effectively navigate the complexities of AI transformation and successfully leverage its potential to drive transformative change. Leaders must operate across different functional domains—technological, strategic, operational, and organizational—while demonstrating technical, adaptive, and interpersonal capacities.
Further, our findings show contingency leadership theories, complexity theory, and transformational leadership theory as relevant theoretical domains for further explaining the different facets of leadership behaviors needed to navigate the multidimensionality of leadership required for AI transformation.
Contingency theories suggest that leadership effectiveness depends on situational factors, which should be considered in future AI implementation studies in the context of AI adaptation and integration within health care organizations [ 68 , 69 ]. Complexity theory provides a framework for examining leadership behaviors in interconnected, dynamic environments where leaders must balance innovation and stability and demonstrate an adaptive approach to challenges, characterized by uncertainty and change [ 70 - 73 ]. Transformational leadership theory emphasizes motivating, empowering, and developing others by fostering trust and collaboration while challenging the status quo to drive organizational change and innovation [ 74 , 75 ]. These theories should be considered in future AI implementation studies within health care organizations.
Future research and training programs related to AI in health care should examine the leadership required for AI transformation through the lens of multidimensionality, providing insights into the interrelatedness of functional domains, leadership capacities, and contextual enablers and barriers, while exploring the key theoretical domains related to contingency, complexity, and transformational leadership to further understand the interpersonal dynamics shaping AI transformation in health care.
Some limitations to our scoping review are worth noting. First, given the contextual variability in the included studies and the methodological variations, we could not establish firm correlations about specific leadership domains, capacities, and contextual factors; the effectiveness of leadership approaches; or the moderating effects of contextual factors. Consequently, we have presented only the overarching emergent themes.
Second, our study is limited by the significant variation in conceptual definitions of leadership and leadership competencies found in the current literature, which often lacks more standardized definitions or instruments for measurement. This variation caused conceptual inconsistencies. We addressed the inconsistencies by clearly defining what constitutes a functional domain, capacity, and context before our data analysis to address this. We iteratively coded the data into themes to ensure all relevant aspects were captured.
Third, our search strategy focused on MEDLINE-indexed journals, which may exclude some newer journals indexed in PubMed but not yet in MEDLINE. While this might limit the capture of the very latest advancements in digital health, it does not diminish the robustness of the review. Fourth, we retrieved only articles written in English, which possibly limited the comprehensiveness of our findings. Fifth, we looked at AI as a system and did not look at the relationship between the implementation of different types of AI tools and leadership behaviors which was beyond the scope of our review. Finally, our analysis used an inductive approach and was not informed by a predetermined theory to aid the mapping of the literature. This may have limited our analysis in capturing different elements of an umbrella theory.
Leading organizations toward AI transformation is an adaptive challenge influenced by a myriad of interwoven situational factors that create a dynamic and intricate environment. The body of literature related to AI in health care is rapidly expanding, and the recommendations imparted by this review, alongside the multidimensional leadership framework ( Figure 2 ), stand poised to guide research and practice to empower health care organizations in their AI transformation journey. Future research on AI transformation, which includes innovation identification, implementation, and scaling, can use this framework to understand the role of leadership in driving successful outcomes.
Further, future research must undergo methodological expansion by embracing qualitative and mixed methods approaches to illuminate the intricate temporal aspects of AI transformation and corresponding evolving leadership behaviors.
In summary, emerging evidence shows that multidimensional leadership plays crucial role in AI transformation in health care organization. Leaders must adeptly balance technology opportunities while demonstrating unwavering empathy for stakeholder needs and nimble adaptability to accommodating the ever-changing contextual landscape, which encompasses the regulatory frameworks, the evolution of technology, and the organization’s priorities.
This work is supported through a grant from the University of Toronto’s Connaught Global Challenges. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the study.
The main study data are the data extraction materials and quality ratings of included papers, most of which are included in the study tables. The data sets generated and analyzed during this study are available from the corresponding author on reasonable request.
All authors were involved in conception and design of the study and approved the protocol. AS and NS were responsible for overseeing the search of databases and literature. AS, NS, and SS were involved in the screening of articles, data extraction and data verification, and analysis of data. All authors were involved in data interpretation, supported in the drafting of the paper, which was led by AS, and all authors supported in revising and formatting of the paper. All authors have provided final approval of the version of the paper submitted for publication, and all authors agree to be accountable for all aspects of the work.
None declared.
Updated PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analysis) checklist.
artificial intelligence |
Preferred Reporting Items for Systematic Reviews and Meta-Analysis extension for Scoping Reviews |
Edited by T de Azevedo Cardoso, G Eysenbach; submitted 14.11.23; peer-reviewed by D Chrimes, TAR Sure, S Kommireddy, J Konopik, M Brommeyer; comments to author 20.02.24; revised version received 12.03.24; accepted 15.07.24; published 14.08.24.
©Abi Sriharan, Nigar Sekercioglu, Cheryl Mitchell, Senthujan Senkaiahliyan, Attila Hertelendy, Tracy Porter, Jane Banaszak-Holl. Originally published in the Journal of Medical Internet Research (https://www.jmir.org), 14.08.2024.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in the Journal of Medical Internet Research (ISSN 1438-8871), is properly cited. The complete bibliographic information, a link to the original publication on https://www.jmir.org/, as well as this copyright and license information must be included.
Communications Chairs 2024 2024 Conference
by Adil Salim, Bo Han, Manuel Gomez Rodriguez, and Rose Yu
We are excited to announce the list of NeurIPS 2024 workshops! We received 204 total submissions — a significant increase from last year. From this great batch of submissions, we have accepted 56 workshops that will take place on Dec. 14 & 15.
Given the exceptional quality of submissions this year, we wish we could have accepted many more, but we could not due to logistical constraints. We want to thank everyone who put in tremendous effort in submitting a workshop proposal.
We continue to use OpenReview as our submission platform this year, which is aligned with other NeurIPS submission tracks due to the success of OpenReview in matching reviewers well to proposals. Additional details about the selection process are provided below.
The requested items for the proposals have not changed much this year. We kept the length of the main proposal limited to three pages and the organizer information limited to two pages, along with unlimited references. We specifically let reviewers know that they need not read beyond those pages. With respect to last year, we have further increased the reviewer pool. We sent out over 418 invitations and managed to recruit 189 reviewers. This resulted in at least two reviews per proposal for (almost) all 204 proposals. We thank all the reviewers for their timely and professional efforts to provide quality reviews that greatly assisted our decision-making and facilitated an exciting and well-informed workshop program this year.
In making our selections, we asked the reviewers to closely follow our Guidance for Workshop Proposals , which was also shared with the proposal authors. Workshop proposals must be reviewed somewhat differently from academic papers, and hence we asked the reviewers to consider both scientific merits and broader impacts in their assessments. We recognize that workshop reviews might be somewhat more subjective than academic paper reviews. To offer feedback to the proposal authors, we have decided to release the review comments.
Individual evaluations of proposals by reviewers were important for the decision process, but they were not the only considerations in the decision process. For example, we also strived for a good balance between research areas, and between applications and theory. As interest across a variety of research areas is not uniform, some areas were more competitive than others. For example, there were many strong proposals surrounding large language models this year and we could not accept all. We attempted some balance of topics to cover both mainstream and emerging topics.
The next step is your contributions! Several workshops have begun soliciting submissions, many using our suggested submission date of Aug 30, 2024. We typically let each workshop advertise its own call for papers (if they plan to include workshop papers). We will communicate with the workshop organizers some additional deadlines to facilitate the successful planning of 56 exciting workshops. Stay tuned for more technical and contextual information coming soon!
On to the best part: the preliminary list of accepted workshops for 2024!
2024 Conference , NeurIPS Newsletters
2024 Conference
Neurips 2024 may newsletter.
IMAGES
COMMENTS
Learn the steps and skills for writing a good scientific review paper, from defining the topic and audience to conducting the literature search and synthesis. Find tips on style, approach, method, and structure for different types of reviews.
Types Of Review Paper. Not all review articles are created equal. Each type has its methodology, purpose, and format, catering to different research needs and questions. Systematic Review Paper. First up is the systematic review, the crème de la crème of review types. It's known for its rigorous methodology, involving a detailed plan for ...
Examples of literature reviews. Step 1 - Search for relevant literature. Step 2 - Evaluate and select sources. Step 3 - Identify themes, debates, and gaps. Step 4 - Outline your literature review's structure. Step 5 - Write your literature review.
Learn from editors and scientists who share their tips and experiences on writing reviews for scientific journals. Find out how to choose a topic, structure a review, avoid jargon, use figures and stay updated.
Many research disciplines feature high-impact journals that are dedicated outlets for review papers (or review-conceptual combinations) (e.g., Academy of Management Review, Psychology Bulletin, Medicinal Research Reviews).The rationale for such outlets is the premise that research integration and synthesis provides an important, and possibly even a required, step in the scientific process.
How to review a paper. A good peer review requires disciplinary expertise, a keen and critical eye, and a diplomatic and constructive approach. Credit: dmark/iStockphoto. As junior scientists develop their expertise and make names for themselves, they are increasingly likely to receive invitations to review research manuscripts.
A literature review is a surveys scholarly articles, books and other sources relevant to a particular. issue, area of research, or theory, and by so doing, providing a description, summary, and ...
An ideal review article should be logically structured and efficiently utilise illustrations, in the form of tables and figures, to convey the key findings and relationships in the study. According to Tay , illustrations often take a secondary role in review papers when compared to primary research papers which are focused on illustrations ...
Just like research papers, the most common and convenient practice is to write review papers in "introduction, methods, results, and discussion (IMRaD)" format accompanied by title, abstract, key words, and references. The title makes the first introductory and is the most important sentence of the review paper.
With research accelerating at an unprecedented speed in recent years and more and more original papers being published, review articles have become increasingly important as a means to keep up-to-date with developments in a particular area of research. A good review article provides readers with an in-depth understanding of a field and ...
The ideal topic should be focused enough to be manageable but with a large enough body of available research to justify the need for a review article. One article on the topic of scientific reviews suggests that at least 15 to 20 relevant research papers published within the previous five years should be easily identifiable to warrant writing a ...
A review article can also be called a literature review, or a review of literature. It is a survey of previously published research on a topic. It should give an overview of current thinking on the topic. And, unlike an original research article, it will not present new experimental results. Writing a review of literature is to provide a ...
Writing the Review. 1Good scientific writing tells a story, so come up with a logical structure for your paper, with a beginning, middle, and end. Use appropriate headings and sequencing of ideas to make the content flow and guide readers seamlessly from start to finish.
3. Identify the article. Start your review by referring to the title and author of the article, the title of the journal, and the year of publication in the first paragraph. For example: The article, "Condom use will increase the spread of AIDS," was written by Anthony Zimmerman, a Catholic priest.
INFOGRAPHIC :5 Differences between a research paper and a review paper. There are different types of scholarly literature. Some of these require researchers to conduct an original study, whereas others can be based on previously published research. Understanding each of these types and also how they differ from one another can be rather ...
Literature reviews are in great demand in most scientific fields. Their need stems from the ever-increasing output of scientific publications .For example, compared to 1991, in 2008 three, eight, and forty times more papers were indexed in Web of Science on malaria, obesity, and biodiversity, respectively .Given such mountains of papers, scientists cannot be expected to examine in detail every ...
WHAT IS A REVIEW PAPER? The purpose of a review paper is to succinctly review recent progress in a particular topic. Overall, the paper summarizes the current state of knowledge of the topic. It creates an understanding of the topic for the reader by discussing the findings presented in recent research papers. A review paper is not a "term ...
A review article is a comprehensive summary of the current understanding of a specific research topic and is based on previously published research. Unlike research papers, it does not contain new results, but can propose new inferences based on the combined findings of previous research. Types of review articles
Writing a literature review requires a range of skills to gather, sort, evaluate and summarise peer-reviewed published data into a relevant and informative unbiased narrative. Digital access to research papers, academic texts, review articles, reference databases and public data sets are all sources of information that are available to enrich ...
A literature review can be a part of a research paper or scholarly article, usually falling after the introduction and before the research methods sections. In these cases, the lit review just needs to cover scholarship that is important to the issue you are writing about; sometimes it will also cover key sources that informed your research ...
Briefly summarize what the paper is about and what the findings are. Try to put the findings of the paper into the context of the existing literature and current knowledge. Indicate the significance of the work and if it is novel or mainly confirmatory. Indicate the work's strengths, its quality and completeness.
Structure: Research papers typically follow a structured format, including key sections like the introduction, methods, results, discussion, and conclusion. Meanwhile, review papers may have a more flexible structure, allowing authors to organize the content based on thematic or chronological approaches. However, they generally include an ...
Structure of a Research Proposal If you want to know how to make a research proposal impactful, include the following components:¹ 1. Introduction This section provides a background of the study, including the research topic, what is already known about it and the gaps, and the significance of the proposed research. 2. Literature review
For a professional paper, the affiliation is the institution at which the research was conducted. Include both the name of any department and the name of the college, university, or other institution, separated by a comma. Center the affiliation on the next double-spaced line after the author names; when there are multiple affiliations, center ...
This review underscores the significant potential of cellulose PADs in facilitating decentralized, cost-effective, and simplified testing methodologies to maintain food safety standards. With the progression of interdisciplinary research, cellulose PADs are expected to become essential platforms for on-site food safety and authentication ...
The fundamental rationale of writing a review article is to make a readable synthesis of the best literature sources on an important research inquiry or a topic. This simple definition of a review article contains the following key elements: The question (s) to be dealt with.
Three research papers on MDMA assisted psychotherapy have been retracted by the journal Psychopharmacology because of "protocol violations amounting to unethical conduct" by researchers at a study site. In the retraction notices the journal said that the authors were aware of the violations when they submitted the articles but failed to disclose them or remove the affected data from their ...
Background Upper gastrointestinal cancers (UGICs) are increasingly prevalent. With a poor prognosis and significant longer-term effects, UGICs present significant adjustment challenges for individuals with cancer and their informal caregivers. However, the supportive care needs of these informal caregivers are largely unknown. This systematic review of qualitative studies synthesises and ...
This paper is in the following e-collection/theme issue: Digital Health Reviews (1207) Artificial Intelligence (1253) E-Health / Health Services Research and New Models of Care (475) E-Health Policy and Health Systems Innovation (214) Digital Health, Telehealth and e-Innovation in Clinical Settings (362) General Articles on Innovation and Technology in Public Health (61)
We recognize that workshop reviews might be somewhat more subjective than academic paper reviews. To offer feedback to the proposal authors, we have decided to release the review comments. Individual evaluations of proposals by reviewers were important for the decision process, but they were not the only considerations in the decision process.